A clinical study is currently underway to evaluate the efficacy and safety of an investigational intravenous medication that could potentially reduce memory loss. You may be eligible if you:

• Are between 50 and 85 years old
• Have a diagnosis of Alzheimer’s disease
• Have a loved one or a person you trust and knows you well available to help you with the study requirements and accompany you to each some of the appointments